Bobak R. Azamian, President/CEO and Board Chair at Tarsus Pharmaceuticals, Inc. (TARS), sold 34,603 shares at $69.42 ($2.4M) on 2026-03-17, disclosed to the SEC on 2026-03-19.
Seasonal sale ($2.4M) by President/CEO and Board Chair — this insider has traded TARS in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.42 | 10,972 | $762K | 32.2% |
| 2 | $68.71 | 11,667 | $802K | 33.9% |
| 3 | $67.00 | 11,964 | $802K | 33.9% |
| Total | $68.34 avg | 34,603 | $2.4M | 100% |
| Filing → |
| TARS | SELL | 2026-06-22 | $615K | — | Filing → |
| TARS | SELL | 2025-12-30 | $944K | — | Filing → |
| TARS | SELL | 2025-09-26 | $332K | — | Filing → |